Results 11 to 20 of about 30,665 (264)

Association of subcutaneous testosterone pellet therapy with developing secondary polycythemia

open access: yesAsian Journal of Andrology, 2018
A variety of methods for testosterone replacement therapy (TRT) exist, and the major potential risks of TRT have been well established. The risk of developing polycythemia secondary to exogenous testosterone (T) has been reported to range from 0.4% to 40%
Katherine Lang Rotker   +6 more
doaj   +2 more sources

Polycythemia in the newborn

open access: yesThe Indian Journal of Pediatrics, 2008
Polycythemia is defined as a venous hematocrit of over 65%. The hematocrit in a newborn peaks at 2 hours of age and decreases gradually after that. The etiology of polycythemia is related either to intra-uterine hypoxia or secondary to fetal transfusion.
M, Jeevasankar   +4 more
openaire   +3 more sources

Introducing heat-not-burn tobacco improves hematocrit and cigarette smoking-related symptoms in patients with smokers' polycythemia and polycythemia vera.

open access: yesPLoS ONE
Cigarette smoking induces relative and absolute erythrocytosis (smokers' polycythemia). In patients with smokers' polycythemia complicated by chronic obstructive pulmonary disease, the incidence and mortality rate of pulmonary embolism increase ...
Kazuhide Iizuka   +17 more
doaj   +2 more sources

Concurrent Polycythemia of Undetermined Etiology and Smouldering Plasma Cell Myeloma

open access: yesCase Reports in Pathology, 2018
The combination of polycythemia and plasma cell myeloma occurring concurrently is very rare and few cases have been reported in the literature. Further, the vast majority of these cases are cases of polycythemia vera and myeloma.
Roula Katerji, Chad A. Hudson
doaj   +2 more sources

Breaking stereotypes - Polycythemia secondary to shisha smoking in a middle-age Swiss woman. [PDF]

open access: yes, 2022
The diagnosis of polycythemia, particularly the secondary forms, can be challenging. The distinction between primary and secondary polycythemia is relevant and has management implications.
Rovó, Alicia, Agbariah, Nada
core   +1 more source

Thromboembolic complications of polycythemia: Polycythemia vera versus smokers' polycythemia [PDF]

open access: yesJournal of Vascular Surgery, 1993
This report compares patients with the hypercoagulable state of polycythemia vera to patients with secondary polycythemia caused by tobacco use to determine whether the incidence of thromboembolic events is equivalent.The medical records of 146 patients with the diagnosis of polycythemia between 1977 to 1990 were reviewed.
T H, Schwarcz   +5 more
openaire   +2 more sources

Testosterone Versus Clomiphene Treatment of Hypogonadism: A Retrospective Analysis in US Veterans. [PDF]

open access: yesAndrology
ABSTRACT Background Male hypogonadotropic hypogonadism is a complex condition with a multifactorial etiology. Although testosterone replacement therapy (TRT) is the only approved treatment for male hypogonadism, clomiphene citrate (CC) is often used as an off‐label treatment.
Tadisina S   +6 more
europepmc   +2 more sources

Studies of JAK2 mutations in myeloproliferative disorders [PDF]

open access: yes, 2008
Myeloproliferative disorders (MPD) are diseases characterized by clonal hematopoiesis with overprodution of mature cells from erythroid, megakaryocytic and myeloid lineages.
Li, Sai
core   +1 more source

Performance of Antenatal Diagnostic Criteria of Twin-Anemia-Polycythemia Sequence. [PDF]

open access: yes, 2020
This study aims to elicit the validation performance of different diagnostic criteria and to evaluate the disease course and perinatal outcomes of pregnancies complicated by twin anemia polycythemia sequence (TAPS).
Erkan Kalafat   +14 more
core   +1 more source

The haematocrit and platelet target in polycythemia vera [PDF]

open access: yes, 2007
Polycythemia vera (PV) is a chronic myeloproliferative disorder whose major morbidity and mortality are thrombohaemorragic events and progression to acute leukaemia or myelofibrosis.
Di Nisio M   +14 more
core   +1 more source

Home - About - Disclaimer - Privacy